Trial record 8 of 10 for:
Longeveron
Lomecel-B Effects on Alzheimer's Disease (CLEARMIND)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05233774 |
|
Recruitment Status :
Completed
First Posted : February 10, 2022
Last Update Posted : February 20, 2024
|
Sponsor:
Longeveron Inc.
Collaborator:
bioRASI, LLC
Information provided by (Responsible Party):
Longeveron Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | September 29, 2023 |
| Actual Study Completion Date : | September 29, 2023 |